αKlotho and vascular calcification: an evolving paradigm.
αKlotho and vascular calcification: an evolving paradigm.
复制标题
αKlotho 和血管钙化:一个不断发展的范例。
DOI:
10.1097/01.mnh.0000447024.97464.a3
复制
发表时间:
2014-07
影响因子:
3.2
通讯作者:
Moe OW
中科院分区:
文献类型:
--
作者:
Hu MC;Kuro-o M;Moe OW
Cardiovascular disease remains the single most serious contributor to mortality in chronic kidney disease (CKD). Although conventional risk factors are prevalent in CKD, both cardiomyopathy and vasculopathy can be caused by pathophysiologic mechanisms specific to the uremic state. CKD is a state of systemic αKlotho deficiency. While the molecular mechanism of action of αKlotho is not well understood, the downstream targets and biologic functions of αKlotho are astonishingly pleiotropic. An emerging body of literature links αKlotho to uremic vasculopathy. The expression of αKlotho in the vasculature is controversial due to conflicting data. Regardless of whether αKlotho acts a circulating or resident protein, there are good data associating changes in αKlotho levels with vascular pathology including vascular calcification and in vitro data of direct action of αKlotho on both the endothelium and vascular smooth muscle cells in terms of cytoprotection and prevention of mineralization. It is critical to understand the pathogenic role of αKlotho on the integral endothelium-vascular smooth muscle network rather than each cell type in isolation in uremic vasculopathy, as αKlotho can serve as a potential prognostic biomarker and a biological therapeutic agent.
登录
查看更多内容
影响因子:
19.6
作者:
通讯作者:
--
影响因子:
3.7
作者:
Kitagawa M;Sugiyama H;Morinaga H;Inoue T;Takiue K;Ogawa A;Yamanari T;Kikumoto Y;Uchida HA;Kitamura S;Maeshima Y;Nakamura K;Ito H;Makino H
通讯作者:
Makino H
DOI:
10.2215/cjn.02700313
发表时间:
2013-11-07
影响因子:
9.8
作者:
Karalliedde, Janaka;Maltese, Giuseppe;Gnudi, Luigi
通讯作者:
Gnudi, Luigi
影响因子:
--
作者:
Hu, Ming Chang;Kuro-o, Makoto;Moe, Orson W.
通讯作者:
Moe, Orson W.
影响因子:
18.2
作者:
Hu MC;Shiizaki K;Kuro-o M;Moe OW
通讯作者:
Moe OW